Log in
Enquire now
‌

US Patent 9962398 Sulfonamide compounds for inhibition of metastatic tumor growth

Patent 9962398 was granted and assigned to Welichem Biotech Inc. on May, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

Therapeutic ureido-sulfonamide compositions having compounds with the formulaR-Q-Ar—SO2NH2 are disclosed, which compounds selectively inhibit CAIX and CAXII, and which are effective to inhibit hypoxic tumor growth, suppress metastases, and impair and deplete cancer stem cells in mammals.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9962398 Sulfonamide compounds for inhibition of metastatic tumor growth

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.